DUBLIN, CA-Supergen Inc., a developer of cancer therapies, has signed a 30,000-square-foot lease renewal at Dublin Corporate Center. The transaction retains the pharmaceutical company’s headquarters at the office campus through the end of 2015.

SuperGen is dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. Supergen tells GlobeSt.com that “we love the location and the fact that we were able to renew our lease at a significant reduction from our initial lease rate was a double bonus for us.” The initial lease was a 10-year lease signed in 2000, and according to Supergen, “the rates were quite high at the time.” He couldn’t provide any further information at this time.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.